Cryo-Cell International Inc. (NYSE AMERICAN: CCEL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CRYO-CELL INTERNATIONAL INC.

Cryo-Cell International Inc. (NYSE AMERICAN: CCEL)
Listen to this Section


$3.53
+0.0280 ( +0.80% ) 0.3K

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.

Market Data


Open $3.53
Previous Close $3.50
Volume 0.3K
Market Cap $27.79M
Day Range $3.50 - $3.61
52 Week Range $2.72 - $6.35
Shares Outstanding 8.06M
Change % +0.80%
Net Change ▲ 0.0280
Insider Ownership 0.00%
Exchange NYSE AMERICAN
SectorHealthcare
IndustryManaged Health Care
IPO Year
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -67,641.00

Date Type Amount Purchased Purchaser
2023-12-28 Sale -50000.00 PORTNOY DAVID
2023-10-12 Sale -5300.00 Berger Harold D.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 10 Nov 12, 2025
4 Insider transactions 1 Nov 12, 2025
4 Insider transactions 1 Nov 04, 2025
8-k 8K-related 10 Oct 23, 2025
4 Insider transactions 1 Oct 23, 2025
4 Insider transactions 1 Oct 23, 2025
10-q Quarterly Reports 71 Oct 15, 2025
ars Annual reports 1 Sep 26, 2025
def Proxies and info statements 4 Sep 26, 2025
4 Insider transactions 1 Sep 18, 2025

Latest News


× Before browsing our site, please accept our cookies policy